Skip to main content
. 2022 Feb 28;37(1):175–179. doi: 10.3803/EnM.2021.1262

Table 1.

Growth Data and Biomarkers of Study Subjects According to Their Genetic Risk

Variable Low risk (n=108) Moderate to high risk (n=111) P value
Age, yr 8.9±0.4 8.8±0.3 0.05
Height SDS 0.67±0.82 0.75±0.92 0.52
Corrected height SDS −0.04±0.84 0.22±0.93 0.03
Weight SDS 0.62 (0.16 to 1.24) 0.71 (0.08 to 1.5) 0.59
BMI SDS 0.31 (−0.28 to 1.17) 0.36 (−0.42 to 1.2) 0.95
Overweight, % 21.3 19.8 0.87
Obese, % 8.3 12.6 0.38
IGF-1, μg/L 157.2±43.7 153.7±40 0.54
IGFBP-3, μg/mL 4.09±0.81 4.26±0.77 0.12
IGF-1/IGFBP-3 molar ratio 0.211±0.039 0.199±0.035 0.03
Δ Height SDS 0.16±0.85 (n=101) 0.18±0.85 (n=101) 0.85
Δ BMI SDS −0.29 (−0.98 to 0.60) (n=101) −0.22 (−1.17 to 0.62) (n=101) 0.83

Values are expressed as mean±1 standard deviation or median (interquartile range).

SDS, standard deviation score; BMI, body mass index; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein 3; Δ, change between the present age and 18 months of age.